ATE341343T1 - Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel - Google Patents

Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel

Info

Publication number
ATE341343T1
ATE341343T1 AT01271867T AT01271867T ATE341343T1 AT E341343 T1 ATE341343 T1 AT E341343T1 AT 01271867 T AT01271867 T AT 01271867T AT 01271867 T AT01271867 T AT 01271867T AT E341343 T1 ATE341343 T1 AT E341343T1
Authority
AT
Austria
Prior art keywords
compositions containing
insulin resistance
improvement agent
resistance improvement
medical compositions
Prior art date
Application number
AT01271867T
Other languages
English (en)
Inventor
Masaya Takaoka
Kazushi Araki
Shoichi Kanda
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE341343T1 publication Critical patent/ATE341343T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT01271867T 2000-12-26 2001-12-21 Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel ATE341343T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000394424 2000-12-26

Publications (1)

Publication Number Publication Date
ATE341343T1 true ATE341343T1 (de) 2006-10-15

Family

ID=18860057

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01271867T ATE341343T1 (de) 2000-12-26 2001-12-21 Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel

Country Status (5)

Country Link
US (2) US7199139B2 (de)
EP (2) EP1695716A2 (de)
AT (1) ATE341343T1 (de)
DE (1) DE60123665T2 (de)
WO (1) WO2002051441A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US6414002B1 (en) 1999-09-22 2002-07-02 Bristol-Myers Squibb Company Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
AU2004270162B2 (en) * 2003-08-28 2010-05-13 Nicox S.A. Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use
AU2003266526A1 (en) 2003-09-17 2005-04-11 Kaname Kawasugi Medicinal composition
US7420083B2 (en) * 2003-09-25 2008-09-02 Wyeth Substituted aryloximes
CN1972715A (zh) * 2004-03-29 2007-05-30 三共株式会社 含有胰岛素抵抗改善剂的糖尿病治疗剂
US7396829B2 (en) * 2005-02-24 2008-07-08 Nitromed, Inc. Nitric oxide enhancing diuretic compounds, compositions and methods of use
EP1951702A2 (de) * 2005-10-17 2008-08-06 NeuroTherapeutics Pharma, Inc. Für die steuerung von erkrankungen des zentralen nervensystems geeignete diuretikaähnliche verbindungsanaloga
MX2008015640A (es) * 2006-06-09 2009-01-09 Wellstat Therapeutics Corp Compuestos para el tratamiento de trastornos metabolicos.
EP2106260B8 (de) * 2007-01-25 2018-04-04 Naia Metabolic, Inc. Insulin-sensibilisatoren und behandlungsverfahren damit
CA2774715C (en) 2009-07-27 2018-04-03 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
CA2802288C (en) 2010-07-02 2018-08-21 Gilead Sciences, Inc. Triazolopyridinone compounds as ion channel modulators
KR20140033377A (ko) 2011-05-10 2014-03-18 길리애드 사이언시즈, 인코포레이티드 나트륨 채널 조절제로서의 융합된 헤테로시클릭 화합물
NO3175985T3 (de) 2011-07-01 2018-04-28
TWI549944B (zh) 2011-07-01 2016-09-21 吉李德科學股份有限公司 作為離子通道調節劑之稠合雜環化合物
CA2849505A1 (en) * 2011-09-21 2013-03-28 Gilead Sciences, Inc. Sodium channel blockers reduce glucagon secretion

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR240698A1 (es) * 1985-01-19 1990-09-28 Takeda Chemical Industries Ltd Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales
FI91869C (fi) * 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
DE10199003I1 (de) * 1987-09-04 2003-06-12 Beecham Group Plc Substituierte Thiazolidinionderivate
JPH0713284Y2 (ja) * 1987-09-21 1995-03-29 株式会社村田製作所 一体成形型誘電体フィルタの共振周波数調整構造
US5594016A (en) * 1992-12-28 1997-01-14 Mitsubishi Chemical Corporation Naphthalene derivatives
CN1045005C (zh) * 1993-04-30 1999-09-08 山之内制药株式会社 双噁二唑烷衍生物,含该化合物的药物组合物及其用途
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
CA2157032C (en) * 1993-12-27 1999-09-28 Hisashi Shinkai Isoxazolidinedione derivative and use thereof
CA2201113A1 (en) * 1994-10-20 1996-05-02 Yutaka Nomura Quinoline derivatives
DE69626958T2 (de) * 1995-03-16 2004-03-18 Pfizer Inc. Verwendung von amlodipin, eines seiner salze oder felodipin in kombination mit einem ace-hemmer zur herstellung eines arzneimittels zur behandlung von nicht ischämischer kongestiver herzinsuffizienz
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
JP3144624B2 (ja) * 1995-06-02 2001-03-12 杏林製薬株式会社 Ｎ−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
ZA967800B (en) * 1995-09-20 1997-04-03 Yamanouchi Pharma Co Ltd Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
GB9604242D0 (en) 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
KR20000005224A (ko) * 1996-04-04 2000-01-25 가와무라 요시부미 페닐알킬카르복실산 유도체_
NZ503712A (en) * 1997-10-02 2003-07-25 Sankyo Co Amidopropionic acid derivatives
WO1999019313A1 (en) 1997-10-27 1999-04-22 Dr. Reddy's Research Foundation Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
SE9801992D0 (sv) 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
CZ20013593A3 (cs) * 1999-04-06 2002-03-13 Sankyo Company, Limited Alfa-Substituované deriváty karboxylových kyselin
TWI249401B (en) * 1999-04-14 2006-02-21 Takeda Chemical Industries Ltd Agent for improving ketosis
TWI284533B (en) 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
PE20010580A1 (es) * 1999-09-03 2001-05-25 Takeda Chemical Industries Ltd Composicion farmaceutica para tratar la diabetes
TW200514783A (en) 1999-09-22 2005-05-01 Bristol Myers Squibb Co Substituted acid derivatives useful as antiodiabetic and antiobesity agents and method
EP1261373A2 (de) * 1999-12-24 2002-12-04 SmithKline Beecham plc Zusammensetzungen zur behandlung von diabetes mellitus, enthaltend einem insulin-sensibilisatormittel und einem mittel zur behandlung von herzzustande
RU2281764C2 (ru) * 2000-03-17 2006-08-20 Адзиномото Ко., Инк. Лекарственные средства для лечения осложнений, связанных с диабетом, и невропатии и их применения
US20020013334A1 (en) * 2000-06-15 2002-01-31 Robl Jeffrey A. HMG-CoA reductase inhibitors and method

Also Published As

Publication number Publication date
US20050288339A1 (en) 2005-12-29
EP1354602A1 (de) 2003-10-22
WO2002051441A1 (fr) 2002-07-04
US7199139B2 (en) 2007-04-03
EP1354602B1 (de) 2006-10-04
DE60123665D1 (de) 2006-11-16
EP1354602A4 (de) 2004-05-06
US20040053974A1 (en) 2004-03-18
EP1695716A2 (de) 2006-08-30
DE60123665T2 (de) 2007-08-16

Similar Documents

Publication Publication Date Title
ATE341343T1 (de) Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel
SE0001899D0 (sv) New compounds
BRPI0407897A (pt) derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios
ATE355065T1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
DE60236541D1 (de) Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
BRPI0207700B8 (pt) mistura de conjugados monodispersa, composição farmacêutica, e, uso de uma mistura substancialmente monodispersa de um conjugado de polipeptídeo de insulina-oligômero
MX2010004549A (es) Composiciones y métodos bacteriostáticos o bactericidas.
HRP20030831B1 (en) Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
BR0015992A (pt) Compostos, utilização dos mesmos, e, associações terapêuticas
ATE495793T1 (de) Antitumorzusammensetzungen welche ecteinascidin 743 enthalten
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
SE0102147D0 (sv) New methods
ATE390124T1 (de) Behandlung von mastitis mit einer kombination aus prednisolon und cephalosporin
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
WO2003008637A3 (en) Use of genotyping in the individualization of therapy
ATE454139T1 (de) Arzneimittel mit shikonin als wirkstoff
EE200300213A (et) SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks
SE0000303D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties